CIMA Strategic Case Study – Mock Exams – May 2019 – Denby Healthcare

Looking to capitalise on the increasing use of technology in Healthcare, Denby is looking to expand its services to include an app.

After weighing up the options to outsource or to develop in house, and settling on establishing a department within Denby to create and manage the app, the company must then consider whether its information strategy is adequate given this new venture and how the success of this project should be measured.

Finally, the company have to deal with the aftermath of a data breach, analysing how this could and should have been prevented, the ethics of dealing with public criticism and the impact on it;s share price.

This mock is difficult. The mock expects students to pay attention to minute details. The mock tests understanding of medical tourism and opportunities in the developing countries and ethical aspects around operations.

The first section looks at international opportunities in developing countries primarily driven by medical tourism. The student is expected to discuss options suitable for international expansion.
The second section requires student to explain factors to be considered for international expansion. The student is also expected to evaluate a proposal received from a foreign country. Though, it looks like a straight case of valuation, it isn’t.

The third section deals with the aspects around form of consideration and post acquisition integration issues. There is also an issue with KHS referrals which could have a serious impact on our business. There is an ethical dimension as well.

This mock is difficult. There is a lot of unseen content to digest and time management is key. The mock looks at the ethical aspects of clinical treatments as well as the strategic, financial and operational aspects of the introduction of new innovative technology.

The first section looks at ethics of overcharging patients as a result of extraneous clinical treatments. It then explains how a balance scorecard can be used to monitor performance especially relating to patient satisfaction.

The second section analyses an innovative new technology to address quality issues relating to clinical treatments. The funding options for this are then discussed.

The third section looks at how lenders assess creditworthiness and how control is exercised via loan covenants. Techniques to improve efficiency and implementing change are also discussed.